S59 Reduction in fatalities following introduction of an initial home oxygen risk mitigation form (IHORM) for all new patients on home oxygen in england and wales

IntroductionHome Oxygen can be ordered by any registered Healthcare professional in England and Wales. There are approximately 130,000 patients on Home Oxygen at any time.No specialist training is required to request Home Oxygen and there was previously no mandatory evaluation of risk before it was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2019-12, Vol.74 (Suppl 2), p.A40
Hauptverfasser: Turner-Wilson, J, Smith, S, Channon, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Suppl 2
container_start_page A40
container_title Thorax
container_volume 74
creator Turner-Wilson, J
Smith, S
Channon, S
description IntroductionHome Oxygen can be ordered by any registered Healthcare professional in England and Wales. There are approximately 130,000 patients on Home Oxygen at any time.No specialist training is required to request Home Oxygen and there was previously no mandatory evaluation of risk before it was requested for patients. However, fatalities and serious incidents occurred, and local risk assessments were developed by several Home Oxygen teams to mitigate these risks. It was identified nationally that a risk evaluation for all new patients should be developed, resulting in the IHORM which was introduced for mandatory use from 1st August 2017.The IHORM identifies a number of risks and has clear actions for clinicians to follow if the patient’s responses are too high risk to install oxygen.MethodIncident data was collated for 2 year periods before and after roll out of the IHORM. Data was categorised into 5 levels oxygen incidents. Data for level 3 (minor), 4 (injury) and 5 (fatality or other serious incidents) was retrospectively analysed.Results454 incidents were reported before and 327 incidents after IHORM introduction.Following the introduction of IHORM:-Level 5 serious incidents associated with smoking and fires reduced by 62%.No incidents related to use of emollients oxygen and air mattresses were reported.Number of falls relating to oxygen tubing fell by 15%.Overall IHORM evaluated risks reduced by 28%.ConclusionThe implementation of compulsory risk assessment using IHORM led to an important reduction in adverse events in home oxygen patients.RecommendationsStandardisation of all reporting including incident levels and terminology by NHS home oxygen suppliers is required.Repeat risk assessment of all current smokers with oxygen insitu as ‘safe’ smokers should be recommended. As health changes may result in increased risk.Education training modules available to NHS staff who complete IHORMStandardisation of ex-smoker definitionRigorous assessment of frailty risksRecognition of NICE COPD Guidelines1 and the future BTS COPD guideline recommendations.ReferenceChronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guideline [NG115] webaccessed 11/7/19 https://www.nice.org.uk/guidance/ng115Abstract S59 Table 1
doi_str_mv 10.1136/thorax-2019-BTSabstracts2019.65
format Article
fullrecord <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2314265650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2314265650</sourcerecordid><originalsourceid>FETCH-LOGICAL-b790-617d982fad64f69f74d5798b9c92962f4068c192f3845662009565d674df90343</originalsourceid><addsrcrecordid>eNpdkc9KAzEQxoMoWKvvEPCgHrYm-ye78aZFbUEptL2HbDdpt2aTmqS0vXnxTXwyn8SsVRAPwzDf_Jhh5gPgAqMexgm59gtj-TaKEabR3XTCS-ctn3nXCj2SHYAOTkkRJTElh6CDUIoikuTkGJw4t0QIFRjnHfAxyejn2_tYVOuZr42GtYaSe65qXwsHpVHKbGo9D7q35hcyEvIWDRBXcGEaAc12Nxca2tq9wCboc_5NSmMbeDkcjMbPV20BuVJQiw1chb7Q3sEA_R0Q9gs9V1xXsI0NV8KdgiPJlRNnP7kLpg_30_4geho9Dvu3T1GZ03AdzitaxJJXJJWEyjytspwWJZ3R8INYpogUM0xjmRRpRkiMEM1IVpHASYqSNOmC8_3YlTWva-E8W5q11WEjixOcxiTgKFA3e6pslmxl64bbHcOItaawvSms9YD9N4WRLPkCJMaITA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314265650</pqid></control><display><type>article</type><title>S59 Reduction in fatalities following introduction of an initial home oxygen risk mitigation form (IHORM) for all new patients on home oxygen in england and wales</title><source>Alma/SFX Local Collection</source><creator>Turner-Wilson, J ; Smith, S ; Channon, S</creator><creatorcontrib>Turner-Wilson, J ; Smith, S ; Channon, S</creatorcontrib><description>IntroductionHome Oxygen can be ordered by any registered Healthcare professional in England and Wales. There are approximately 130,000 patients on Home Oxygen at any time.No specialist training is required to request Home Oxygen and there was previously no mandatory evaluation of risk before it was requested for patients. However, fatalities and serious incidents occurred, and local risk assessments were developed by several Home Oxygen teams to mitigate these risks. It was identified nationally that a risk evaluation for all new patients should be developed, resulting in the IHORM which was introduced for mandatory use from 1st August 2017.The IHORM identifies a number of risks and has clear actions for clinicians to follow if the patient’s responses are too high risk to install oxygen.MethodIncident data was collated for 2 year periods before and after roll out of the IHORM. Data was categorised into 5 levels oxygen incidents. Data for level 3 (minor), 4 (injury) and 5 (fatality or other serious incidents) was retrospectively analysed.Results454 incidents were reported before and 327 incidents after IHORM introduction.Following the introduction of IHORM:-Level 5 serious incidents associated with smoking and fires reduced by 62%.No incidents related to use of emollients oxygen and air mattresses were reported.Number of falls relating to oxygen tubing fell by 15%.Overall IHORM evaluated risks reduced by 28%.ConclusionThe implementation of compulsory risk assessment using IHORM led to an important reduction in adverse events in home oxygen patients.RecommendationsStandardisation of all reporting including incident levels and terminology by NHS home oxygen suppliers is required.Repeat risk assessment of all current smokers with oxygen insitu as ‘safe’ smokers should be recommended. As health changes may result in increased risk.Education training modules available to NHS staff who complete IHORMStandardisation of ex-smoker definitionRigorous assessment of frailty risksRecognition of NICE COPD Guidelines1 and the future BTS COPD guideline recommendations.ReferenceChronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guideline [NG115] webaccessed 11/7/19 https://www.nice.org.uk/guidance/ng115Abstract S59 Table 1</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thorax-2019-BTSabstracts2019.65</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Chronic obstructive pulmonary disease ; Fatalities ; Risk assessment ; Subacute care ; Terminology</subject><ispartof>Thorax, 2019-12, Vol.74 (Suppl 2), p.A40</ispartof><rights>Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Turner-Wilson, J</creatorcontrib><creatorcontrib>Smith, S</creatorcontrib><creatorcontrib>Channon, S</creatorcontrib><title>S59 Reduction in fatalities following introduction of an initial home oxygen risk mitigation form (IHORM) for all new patients on home oxygen in england and wales</title><title>Thorax</title><description>IntroductionHome Oxygen can be ordered by any registered Healthcare professional in England and Wales. There are approximately 130,000 patients on Home Oxygen at any time.No specialist training is required to request Home Oxygen and there was previously no mandatory evaluation of risk before it was requested for patients. However, fatalities and serious incidents occurred, and local risk assessments were developed by several Home Oxygen teams to mitigate these risks. It was identified nationally that a risk evaluation for all new patients should be developed, resulting in the IHORM which was introduced for mandatory use from 1st August 2017.The IHORM identifies a number of risks and has clear actions for clinicians to follow if the patient’s responses are too high risk to install oxygen.MethodIncident data was collated for 2 year periods before and after roll out of the IHORM. Data was categorised into 5 levels oxygen incidents. Data for level 3 (minor), 4 (injury) and 5 (fatality or other serious incidents) was retrospectively analysed.Results454 incidents were reported before and 327 incidents after IHORM introduction.Following the introduction of IHORM:-Level 5 serious incidents associated with smoking and fires reduced by 62%.No incidents related to use of emollients oxygen and air mattresses were reported.Number of falls relating to oxygen tubing fell by 15%.Overall IHORM evaluated risks reduced by 28%.ConclusionThe implementation of compulsory risk assessment using IHORM led to an important reduction in adverse events in home oxygen patients.RecommendationsStandardisation of all reporting including incident levels and terminology by NHS home oxygen suppliers is required.Repeat risk assessment of all current smokers with oxygen insitu as ‘safe’ smokers should be recommended. As health changes may result in increased risk.Education training modules available to NHS staff who complete IHORMStandardisation of ex-smoker definitionRigorous assessment of frailty risksRecognition of NICE COPD Guidelines1 and the future BTS COPD guideline recommendations.ReferenceChronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guideline [NG115] webaccessed 11/7/19 https://www.nice.org.uk/guidance/ng115Abstract S59 Table 1</description><subject>Chronic obstructive pulmonary disease</subject><subject>Fatalities</subject><subject>Risk assessment</subject><subject>Subacute care</subject><subject>Terminology</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkc9KAzEQxoMoWKvvEPCgHrYm-ye78aZFbUEptL2HbDdpt2aTmqS0vXnxTXwyn8SsVRAPwzDf_Jhh5gPgAqMexgm59gtj-TaKEabR3XTCS-ctn3nXCj2SHYAOTkkRJTElh6CDUIoikuTkGJw4t0QIFRjnHfAxyejn2_tYVOuZr42GtYaSe65qXwsHpVHKbGo9D7q35hcyEvIWDRBXcGEaAc12Nxca2tq9wCboc_5NSmMbeDkcjMbPV20BuVJQiw1chb7Q3sEA_R0Q9gs9V1xXsI0NV8KdgiPJlRNnP7kLpg_30_4geho9Dvu3T1GZ03AdzitaxJJXJJWEyjytspwWJZ3R8INYpogUM0xjmRRpRkiMEM1IVpHASYqSNOmC8_3YlTWva-E8W5q11WEjixOcxiTgKFA3e6pslmxl64bbHcOItaawvSms9YD9N4WRLPkCJMaITA</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Turner-Wilson, J</creator><creator>Smith, S</creator><creator>Channon, S</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201912</creationdate><title>S59 Reduction in fatalities following introduction of an initial home oxygen risk mitigation form (IHORM) for all new patients on home oxygen in england and wales</title><author>Turner-Wilson, J ; Smith, S ; Channon, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b790-617d982fad64f69f74d5798b9c92962f4068c192f3845662009565d674df90343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Chronic obstructive pulmonary disease</topic><topic>Fatalities</topic><topic>Risk assessment</topic><topic>Subacute care</topic><topic>Terminology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turner-Wilson, J</creatorcontrib><creatorcontrib>Smith, S</creatorcontrib><creatorcontrib>Channon, S</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turner-Wilson, J</au><au>Smith, S</au><au>Channon, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S59 Reduction in fatalities following introduction of an initial home oxygen risk mitigation form (IHORM) for all new patients on home oxygen in england and wales</atitle><jtitle>Thorax</jtitle><date>2019-12</date><risdate>2019</risdate><volume>74</volume><issue>Suppl 2</issue><spage>A40</spage><pages>A40-</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>IntroductionHome Oxygen can be ordered by any registered Healthcare professional in England and Wales. There are approximately 130,000 patients on Home Oxygen at any time.No specialist training is required to request Home Oxygen and there was previously no mandatory evaluation of risk before it was requested for patients. However, fatalities and serious incidents occurred, and local risk assessments were developed by several Home Oxygen teams to mitigate these risks. It was identified nationally that a risk evaluation for all new patients should be developed, resulting in the IHORM which was introduced for mandatory use from 1st August 2017.The IHORM identifies a number of risks and has clear actions for clinicians to follow if the patient’s responses are too high risk to install oxygen.MethodIncident data was collated for 2 year periods before and after roll out of the IHORM. Data was categorised into 5 levels oxygen incidents. Data for level 3 (minor), 4 (injury) and 5 (fatality or other serious incidents) was retrospectively analysed.Results454 incidents were reported before and 327 incidents after IHORM introduction.Following the introduction of IHORM:-Level 5 serious incidents associated with smoking and fires reduced by 62%.No incidents related to use of emollients oxygen and air mattresses were reported.Number of falls relating to oxygen tubing fell by 15%.Overall IHORM evaluated risks reduced by 28%.ConclusionThe implementation of compulsory risk assessment using IHORM led to an important reduction in adverse events in home oxygen patients.RecommendationsStandardisation of all reporting including incident levels and terminology by NHS home oxygen suppliers is required.Repeat risk assessment of all current smokers with oxygen insitu as ‘safe’ smokers should be recommended. As health changes may result in increased risk.Education training modules available to NHS staff who complete IHORMStandardisation of ex-smoker definitionRigorous assessment of frailty risksRecognition of NICE COPD Guidelines1 and the future BTS COPD guideline recommendations.ReferenceChronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guideline [NG115] webaccessed 11/7/19 https://www.nice.org.uk/guidance/ng115Abstract S59 Table 1</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/thorax-2019-BTSabstracts2019.65</doi></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2019-12, Vol.74 (Suppl 2), p.A40
issn 0040-6376
1468-3296
language eng
recordid cdi_proquest_journals_2314265650
source Alma/SFX Local Collection
subjects Chronic obstructive pulmonary disease
Fatalities
Risk assessment
Subacute care
Terminology
title S59 Reduction in fatalities following introduction of an initial home oxygen risk mitigation form (IHORM) for all new patients on home oxygen in england and wales
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A23%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S59%E2%80%85Reduction%20in%20fatalities%20following%20introduction%20of%20an%20initial%20home%20oxygen%20risk%20mitigation%20form%20(IHORM)%20for%20all%20new%20patients%20on%20home%20oxygen%20in%20england%20and%20wales&rft.jtitle=Thorax&rft.au=Turner-Wilson,%20J&rft.date=2019-12&rft.volume=74&rft.issue=Suppl%202&rft.spage=A40&rft.pages=A40-&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thorax-2019-BTSabstracts2019.65&rft_dat=%3Cproquest_bmj_p%3E2314265650%3C/proquest_bmj_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2314265650&rft_id=info:pmid/&rfr_iscdi=true